Pharma Services Category of Avra Laboratories Pvt. Ltd.

- Service Details

Avra Laboratories is a Hyderabad based contract research & manufacturing services (CRAMS) company focused on: Providing high-end contract research and manufacturing services; Manufacturing of niche intermediates and APIs covering various therapeutic areas including oncology.

- Service Details

Avra’s aim is to become a destination for international pharmaceutical companies that require chemistry based support for process optimization and development towards commercial production of APIs and advanced intermediates.

- Service Details

Avra’s primary focus is to provide synthetic chemistry services that include route identification and optimization to enable preparation of compounds on a multi-gram to multi-ton scale.

- Service Details

Avra’s primary focus is to provide synthetic chemistry services that include route identification and optimization to enable preparation of compounds on a multi-gram to multi-ton scale.

- Service Details

Avra service offering is related to developing commercially viable and competitive routes to manufacture key starting materials, advanced intermediates and APIs that may involve multi-step manufacturing processes.

- Service Details

The company has expertise in handling cryogenic reactions and can perform cross-coupling reactions and carbonylation reactions on a large scale

- Service Details

Avra has capabilities in chiral synthesis and separations which have been demonstrated in the large scale synthesis of complex products such as Camptothecin derivatives and Prostaglandins.

- Service Details

Avra’s primary focus is to provide synthetic chemistry services that include route identification and optimization to enable preparation of compounds on a multi-gram to multi-ton scale.

- Service Details

Avra has capabilities in chiral synthesis and separations which have been demonstrated in the large scale synthesis of complex products such as Camptothecin derivatives and Prostaglandins.

- Service Details

Avra has segregated high containment facilities and production areas for early stage development, scale-up and commercial manufacture of high-potency drug substance and drug products, with occupational exposure limits (OEL) ranging from 10 ?g/m3 down to 1 ?g/m3.